Lactic-co-glycolic Acid Polymer with Rapamycin Coated Stent Reduces Neo-Intimal Formation in a Porcine Coronary Model

徐卫亭,霍勇,陈明,李拥军,洪涛,高炜
DOI: https://doi.org/10.3969/j.issn.1001-1439.2004.11.015
2004-01-01
Journal of Clinical Cardiology
Abstract:Objective:Determine the efficacy of two diffient released rapamycin coated stents via PLGA (poly/lactic-co-glycolic acid) polymer to reduce in-stent neointimal hyperplasia. Method: Stents were coated with PLGA polymer containing 65~90 μg(1 μg/mm 2) rapamycin (slow release) or 68~96 μg (1 μg/mm 2) rapamycin (fast release) respectively. Twenty stents (metal group, n=8; slow released group, n=5; fast released group, n=7) were implanted in the coronary arteries of 20 pigs. Result:After 28 days, the mean neointimal was ( 2.18± 1.03)mm 2 for the metal group. Compared with metal group the mean neointimal was significantly decresed in the slow released group [( 1.09± 0.82)mm 2, P 0.05] and the fast released group [( 0.94± 0.88)mm 2, P 0.05]. The in-stent restenosis was 25% in metal group and 0% in two rapamycin group after 28 days. Conclusion:Stent-based delivery of Rapa via PLGA polymer is feasible and effectively reduces in-stent neointimal hyperplasia by inhibiting cellular proliferation.
What problem does this paper attempt to address?